Literature DB >> 9822181

Myocardial protection for neonates and infants.

R A Jonas1.   

Abstract

This report reviews developmental differences between mature and immature myocardium. These differences, which are structural, biochemical, and functional, probably explain the differences which are observed between mature and immature myocardium with respect to resistance to ischemia. Although there are some clinical reports and also laboratory reports suggesting that immature myocardium ist more susceptible to ischemic injury than mature myocardium, it is our impression at Children's Hospital, Boston, that immature myocardium is in fact more resistant to ischemia. A decrease in cardiac output is frequently seen after cardiac surgery though it per se is rarely a cause of death. Factors which exacerbate postoperative low cardiac output include mechanical factors such as distention and retraction, injury to coronary artery branches or direct injury to the myocardium with a ventriculostomy, as well as various perfusion and reperfusion factors such as pH. A recently completed prospective clinical trial at our hospital has revealed that cardiac output is consistently higher with pH stat relative to alpha stat. The ideal recipe for cardioplegia for immature myocardium remains poorly defined. The age at which the transition occurs to mature myocardium also remains to be defined in humans.

Entities:  

Mesh:

Year:  1998        PMID: 9822181     DOI: 10.1055/s-2007-1013087

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  4 in total

1.  Programming of adult cardiovascular disease following exposure to late-gestation hyperglycemia.

Authors:  Melissa Agoudemos; Benjamin E Reinking; Stacia L Koppenhafer; Jeffrey L Segar; Thomas D Scholz
Journal:  Neonatology       Date:  2011-04-01       Impact factor: 4.035

2.  Myocardial cytochrome oxidase activity increases with age and hypoxemia in patients with congenital heart disease.

Authors:  Michael Onwugbufor; Richard J Levy; David Zurakowski; Richard A Jonas; Pranava Sinha
Journal:  Perfusion       Date:  2016-12-05       Impact factor: 1.972

3.  Reversal of oxidant-mediated biochemical injury and prompt functional recovery after prolonged single-dose crystalloid cardioplegic arrest in the infantile piglet heart by terminal warm-blood cardioplegia supplemented with phosphodiesterase III inhibitor.

Authors:  Katsushi Kinouchi; Kiyozo Morita; Yoshihiro Ko; Ryuichi Nagahori; Gen Shinohara; Takayuki Abe; Kazuhiro Hashimoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-02-12

4.  Cardioprotection of neonatal heart using normothermic hyperkalaemia: the importance of delivery and terminal cardioplegia.

Authors:  Hajime Imura; M-Saadeh Suleiman
Journal:  Mol Cell Biochem       Date:  2007-11-25       Impact factor: 3.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.